Metrics as of 10/16/2026, 12:43 PM (Berlin time), refresh in progress.
InfuSystem Holdings Stock
InfuSystem Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Carrie A. Lachance
- Employees
- 467
- Market cap
- $266 M
- IPO
- 27/12/2007
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment…
InfuSystem Holdings stock: price history
1D
-4.0%
1W
-1.4%
1M
+7.4%
6M
+26.4%
YTD
+49.1%
1Y
+43.9%
2Y
+89.4%
5Y
+3.9%
10Y
+428.5%
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~90% stronger price swings than usual
InfuSystem Holdings stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about InfuSystem Holdings
Analyst assessment of InfuSystem Holdings
PRICE TARGET LOW
US$15.00
CONSENSUS
US$15.00
MEDIAN
US$15.00
PRICE TARGET HIGH
US$15.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 05/08/2026
InfuSystem Holdings stock metrics
P/E
31.81
P/B
4.55
EV/EBITDA
11.1
RETURN ON EQUITY
5.5%
NET MARGIN
8.7%
DEBT/EQUITY
0.39
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.1%
FLOAT SHARES
18,740,673
AVG. DAILY VOLUME (30D)
130,664
Insider transactions (SEC)
Funke Jerod
Funke Jerod
Shuda Scott
Chupa Addam
Chupa Addam
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about InfuSystem Holdings stock
What does InfuSystem Holdings do?
InfuSystem Holdings, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Carrie A. Lachance, the company employs around 467 people.
The IPO was on 27/12/2007; the stock trades on AMEX under the ticker INFU.
What do analysts say about InfuSystem Holdings stock?
4 analysts rate the stock, the consensus is Buy (as of 05/08/2026).
The average price target is US$15.00, ranging from US$15.00 to US$15.00, with a median of US$15.00.
This is an external assessment, not a statement by Market Jury.
When does InfuSystem Holdings report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 90% stronger than usual.
Does InfuSystem Holdings pay a dividend?
No, InfuSystem Holdings currently does not pay a dividend.
Which stocks are comparable to InfuSystem Holdings?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get InfuSystem Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess InfuSystem Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.